arrow
J

Jasia Mahdi

baylor college of medicine
H-index:9
Citation Count:1,313
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Macrophages as gatekeepers of glioma progression

巨噬细胞作为胶质瘤进展的守门人

2026-06-180
OAAI
Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas

利用生物标志物治疗弥漫性内生性脑桥胶质瘤

2026-05-120
PRE
EVALUATION OF B7-H3 IMMUNOHISTOCHEMISTRY IN HIGH-GRADE GLIOMAS FOR CHIMERIC ANTIGEN RECEPTOR T-CELL PREDICTIVE TESTING

B7-H3免疫组织化学在高级别胶质瘤中用于嵌合抗原受体T细胞预测性检测的评价

2025-11-010
OAAI
HUMANIZED ANTI-CAR ANTIBODIES AFFECT DURABLE RESPONSE TO GD2-CAR T-CELLS IN DIFFUSE MIDLINE GLIOMA

人源化抗CAR抗体影响弥漫性中线胶质瘤中GD2-CAR T细胞的持久应答

2025-11-010
OAAI
Phase I study of intravenous and intracerebroventricular C7R-GD2.CAR T cell therapy for pediatric central nervous system (CNS) tumors

I期研究:静脉内和脑室内心肌内C7R-GD2.CAR T细胞疗法治疗儿童中枢神经系统(CNS)肿瘤

2025-11-010
OAAI
SINGLE-CELL LANDSCAPE OF B7H3-CAR T THERAPY IN GLIOMA: MECHANISMS OF RESISTANCE AND SIGNATURES OF LONG-TERM RESPONSE

单细胞景观揭示B7H3-CAR T疗法在胶质瘤中的抗药机制及长期应答特征

2025-11-010
PRE
Clinical Impact of Intratumoral Cyst Decompression in Diffuse Intrinsic Pontine Glioma Patients: A Retrospective Analysis

弥漫性内生性脑桥胶质瘤患者中肿瘤内囊肿减压的临床影响:一项回顾性分析

2025-11-010
OAAI
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review

中枢神经系统肿瘤经CAR T细胞疗法治疗后的神经毒性:一项综述

2025-10-310
PRE
The promise of immunotherapy for central nervous system tumours

免疫疗法治疗中枢神经系统肿瘤的潜力

2025-10-060
PRE
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas

正反观点:成人BRAF突变高级别胶质瘤的一线BRAF抑制治疗

2025-07-010
OA
CHROMOSOMAL LOSSES CORRELATE WITH POOR OVERALL SURVIVAL IN H3K27M-ALTERED DIFFUSE MIDLINE GLIOMAS
2024-11-110
PRE
MYELOID POPULATIONS MODULATE GD2 CAR T CELL ACTIVITY IN DIFFUSE MIDLINE GLIOMA
2024-11-110
PRE
TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS

肿瘤炎症相关神经毒性 (TIAN): 中枢神经系统肿瘤免疫治疗患者的毒性综合征

2024-06-180
OAAI
SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS
2024-06-180
OAAI
TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
2023-06-120
OAAI
Tumor inflammation-associated neurotoxicity

肿瘤炎症相关神经毒性

2023-04-0647
OA
Immune signatures of GD2 CAR T cell activity in H3K27M+diffuse midline glioma patients
2023-04-040
PRE
Stroke Mimics Are Not Benign in Immunocompromised Children
STROKE
IF8.9
2022-10-010
OA
GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG
2021-06-014
OAAI
STROKE MIMICS ARE NOT BENIGN IN IMMUNOCOMPROMISED CHILDREN
2021-06-010
OAAI